Actinium Pharmaceuticals, Inc.
ATNM
$1.26
$0.1614.55%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.89M | -34.60M | -41.04M | -45.51M | -38.24M |
| Total Depreciation and Amortization | 821.00K | 819.00K | 815.00K | 800.00K | 811.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.19M | 10.38M | 11.61M | 12.79M | 5.29M |
| Change in Net Operating Assets | -704.00K | -1.65M | -2.08M | -1.35M | -932.00K |
| Cash from Operations | -24.58M | -25.04M | -30.69M | -33.27M | -33.07M |
| Capital Expenditure | -104.00K | 0.00 | 0.00 | 0.00 | -11.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -104.00K | 0.00 | 0.00 | 0.00 | -11.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.00K | -9.00K | -9.00K | -9.00K | -9.00K |
| Issuance of Common Stock | -- | -- | 4.60M | 14.56M | 29.33M |
| Repurchase of Common Stock | -207.00K | -208.00K | -1.00K | -1.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -217.00K | -217.00K | 4.59M | 14.55M | 29.32M |
| Foreign Exchange rate Adjustments | 6.00K | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.90M | -25.26M | -26.10M | -18.72M | -3.76M |